Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group, Inc. (Nasdaq: PRVA) is a technology-driven physician enablement company that regularly issues detailed updates on its operations, value-based care performance, and network expansion. Its news flow often includes quarterly financial results, guidance updates, and announcements related to Accountable Care Organizations (ACOs) and partnerships with independent physician groups.
Investors following PRVA news can expect recurring earnings releases that highlight metrics such as total revenue, gross profit, operating income, net income, Adjusted EBITDA, Implemented Providers, Value-Based Care Attributed Lives, Practice Collections, Care Margin, and Platform Contribution. The company frequently discusses its performance in the Medicare Shared Savings Program (MSSP) and other value-based arrangements, including aggregate shared savings achieved by its Privia Quality Network ACOs.
Privia Health also uses news releases to announce strategic transactions and geographic expansion. Recent examples include a definitive agreement to acquire an ACO business from Evolent Health, Inc., which serves more than 120,000 attributed lives, and entry into the Arizona market through a partnership with Integrated Medical Services, Inc., a large independent multi-specialty practice. These updates provide insight into how the company is growing its presence across 15 states and the District of Columbia and increasing the number of attributed lives in value-based care arrangements.
In addition, PRVA news may cover governance and board changes, such as the appointment of new directors with technology and cybersecurity expertise. For readers interested in physician enablement, value-based care, and healthcare technology, the Privia Health news feed offers a view into how the company reports its progress, adjusts its full-year guidance, and describes the performance of its physician networks and ACOs over time.
Amalgam Rx and Privia Health have announced a collaboration to enhance provider workflows through EHR-integrated services. This partnership aims to simplify value-based care, clinical trial recruitment, and medication safety. Notable offerings from Amalgam include Payer Configured Value-Based Care Rules, Clinical Trial Recruitment tools, and Medication Safety algorithms. This collaboration aligns with Privia's strategy to reduce costs and improve patient outcomes as it moves towards value-based care.
ARLINGTON, Va., Feb. 15, 2022 — Privia Health Group (Nasdaq: PRVA) will participate in a virtual fireside chat during the SVB Leerink 11th Annual Global Healthcare Conference on February 16, 2022, at 4:20 pm ET. The event will be accessible through a webcast along with a replay and accompanying slide presentation available on their website.
Privia Health is a technology-driven company focused on enhancing physician practices, patient experiences, and healthcare outcomes.
On February 14, 2022, Javara announced a clinical trial for an investigational vaccine, mRNA-1345, aimed at preventing respiratory syncytial virus (RSV) in adults aged 60 and older. This trial, conducted in partnership with Privia Health and Moderna (Nasdaq: MRNA), will enroll approximately 34,000 participants across Fayetteville, Annapolis, and Fort Worth. RSV causes significant health issues, with over 177,000 hospitalizations yearly among older adults in the U.S. The trial aims to evaluate the vaccine's safety and efficacy, addressing the urgent need for preventive measures against RSV.
Privia Health Group, Inc. (Nasdaq: PRVA) and Surgery Partners, Inc. (Nasdaq: SGRY) announced a strategic partnership to enhance healthcare delivery in Montana. This agreement grants Privia access to the Great Falls Clinic, a multi-specialty practice with 65 providers, serving as a base for building a statewide network.
Privia Health will also manage the newly established Privia Management Company of Montana, focusing on clinical operations and performance services. The partnership aims to improve patient care while expanding both companies' operational capacities in Montana.
ARLINGTON, Va., Jan. 31, 2022 - Privia Health Group, Inc. (Nasdaq: PRVA) will release its fourth quarter and full year financial results for 2021 on March 25, 2022, before the market opens. The press release will be available at ir.priviahealth.com by 7:00 AM ET. Following this, the management will hold a conference call at 8:00 AM ET to discuss the results and future outlook. Interested parties can access the call via a webcast or by phone. The recording will be available for replay shortly after the call.
Privia Health Group, Inc. (Nasdaq: PRVA) has launched three new Accountable Care Organizations (ACOs) in Maryland, Florida, and Tennessee, bringing the total to seven ACOs in its portfolio. Effective January 1, 2022, the Privia Quality Network now includes over 1,900 independent providers serving 168,000+ Medicare beneficiaries. Four ACOs have transitioned to the MSSP Enhanced Track, which entails significant financial risks. In 2020, Privia achieved $86.5 million in shared savings through MSSP, with total savings exceeding $576 million since 2014.
Privia Health Group, Inc. (Nasdaq: PRVA) has appointed Jeffrey S. Sherman as Executive Vice President and Chief Financial Officer, effective immediately. Sherman, who brings significant financial and healthcare experience from previous roles, will oversee finance and accounting activities. Privia Health CEO Shawn Morris emphasized that Sherman’s background will support the company’s growth and long-term value creation. Sherman succeeds David Mountcastle, who is leaving the company after a successful tenure. Privia Health focuses on optimizing physician practices and enhancing patient experiences.
Privia Health Group, Inc. (Nasdaq: PRVA) has announced new capitated arrangements with HealthFirst Health Plan and Humana for its Accountable Care Organizations (ACOs) in Florida and the Mid-Atlantic region. Effective January 1, 2022, these agreements will provide healthcare services to approximately 23,000 Medicare Advantage beneficiaries. The company expects to generate $230 million in practice collections and GAAP revenue from these contracts in 2022, marking a shift from fee-for-service to care management fees for enhanced healthcare services.
ARLINGTON, Va., Jan. 04, 2022 – Privia Health Group, Inc. (Nasdaq: PRVA) will participate in the 40th Annual J.P. Morgan Healthcare Conference. The management team is scheduled to present a business overview during a virtual fireside chat on January 10, 2022, at 3:00 PM ET. A webcast, replay, and accompanying slide presentation will be available on their investor relations website.
Privia Health is a technology-driven physician enablement company that collaborates with medical groups and health systems to optimize practices, improve patient experiences, and enhance healthcare quality.
Privia Health Group, Inc. (Nasdaq: PRVA) has priced its public offering of 6,000,000 shares of common stock at $29.00 per share. The offering, initiated by selling stockholders, includes a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this secondary offering, which is set to close on November 23, 2021. The offering is managed by leading financial institutions including Goldman Sachs and J.P. Morgan. Forward-looking statements highlight potential uncertainties regarding the completion of the offering.
FAQ
What is the current stock price of Privia Health Group (PRVA)?
What is the market cap of Privia Health Group (PRVA)?
